Woodcock urges USPTO to tighten drug patent oversight


Acting FDA Commissioner Janet Woodcock sent a letter urging the US Patent and Trademark Office to act on anticompetitive patent practices in the pharmaceutical industry. Woodcock raised concerns about patents for small product changes and the practice of moving patients to new formulations, citing a study that found existing drugs accounted for 78% of new drug patents listed from 2005 to 2015.

Full story:

SNMMI SmartBrief

Nuclear medicine, molecular imaging and therapy

Designed specifically for nuclear medicine and molecular imaging professionals, SNMMI SmartBrief is a FREE, daily e-mail newsletter. It provides the latest news and information to save you time and keep you informed on our profession.